Emmaus Life Sciences Inc
(EMMA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,453 | -3,733 | -10,625 | -15,946 | 1,354 |
| Depreciation Amortization | 730 | 2,600 | 1,868 | 1,869 | 4,087 |
| Accounts receivable | 2,900 | -5,149 | 607 | -845 | 1,953 |
| Other Working Capital | 4,200 | -2,617 | 2,209 | 2,110 | -2,834 |
| Other Operating Activity | -3,663 | 7,396 | 868 | 11,558 | -7,011 |
| Operating Cash Flow | $-2,286 | $-1,503 | $-5,073 | $-1,254 | $-2,451 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 35,601 |
| PPE Investments | -8 | -17 | -26 | -73 | -15 |
| Purchase Of Investment | N/A | -2,647 | -5,280 | -6,304 | -3,956 |
| Sale Of Investment | 2,508 | 2,232 | 2,919 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -26,160 |
| Investing Cash Flow | $2,500 | $-432 | $-2,387 | $-6,377 | $5,470 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,111 | 9,977 | 10,368 | 16,190 | 2,765 |
| Debt Repayment | -5,464 | -7,500 | -3,135 | -8,779 | -5,217 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 142 |
| Financing Cash Flow | $-1,353 | $2,477 | $7,233 | $7,411 | $-2,310 |
| Exchange Rate Effect | -19 | -16 | -31 | 12 | 9 |
| Beginning Cash Position | 2,547 | 2,021 | 2,279 | 2,487 | 1,769 |
| End Cash Position | 1,389 | 2,547 | 2,021 | 2,279 | 2,487 |
| Net Cash Flow | $-1,158 | $526 | $-258 | $-208 | $718 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,286 | -1,503 | -5,073 | -1,254 | -2,451 |
| Capital Expenditure | -12 | -17 | -26 | -73 | -15 |
| Free Cash Flow | -2,298 | -1,520 | -5,099 | -1,327 | -2,466 |